These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1004 related items for PubMed ID: 15117438

  • 1. Faecal calprotectin: a new marker for Crohn's disease?
    Wassell J, Dolwani S, Metzner M, Losty H, Hawthorne A.
    Ann Clin Biochem; 2004 May; 41(Pt 3):230-2. PubMed ID: 15117438
    [Abstract] [Full Text] [Related]

  • 2. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 3. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
    Silberer H, Küppers B, Mickisch O, Baniewicz W, Drescher M, Traber L, Kempf A, Schmidt-Gayk H.
    Clin Lab; 2005 Jul; 51(3-4):117-26. PubMed ID: 15819166
    [Abstract] [Full Text] [Related]

  • 4. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D.
    Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
    [Abstract] [Full Text] [Related]

  • 5. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
    Schröder O, Naumann M, Shastri Y, Povse N, Stein J.
    Aliment Pharmacol Ther; 2007 Oct 01; 26(7):1035-42. PubMed ID: 17877510
    [Abstract] [Full Text] [Related]

  • 6. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.
    Am J Gastroenterol; 2008 Jan 01; 103(1):162-9. PubMed ID: 17916108
    [Abstract] [Full Text] [Related]

  • 7. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F.
    Dis Colon Rectum; 2007 Oct 01; 50(10):1697-706. PubMed ID: 17762964
    [Abstract] [Full Text] [Related]

  • 8. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP, McNicholl AG.
    Dig Liver Dis; 2009 Jan 01; 41(1):56-66. PubMed ID: 18602356
    [Abstract] [Full Text] [Related]

  • 9. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
    Malícková K, Janatková I, Bortlík M, Komárek V, Lukás M.
    Epidemiol Mikrobiol Imunol; 2008 Nov 01; 57(4):147-53. PubMed ID: 19069028
    [Abstract] [Full Text] [Related]

  • 10. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Seibold F.
    Am J Gastroenterol; 2010 Jan 01; 105(1):162-9. PubMed ID: 19755969
    [Abstract] [Full Text] [Related]

  • 11. Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammation.
    Gearry R, Barclay M, Florkowski C, George P, Walmsley T.
    N Z Med J; 2005 May 06; 118(1214):U1444. PubMed ID: 15886739
    [No Abstract] [Full Text] [Related]

  • 12. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
    Chang MH, Chou JW, Chen SM, Tsai MC, Sun YS, Lin CC, Lin CP.
    Mol Med Rep; 2014 Jul 06; 10(1):522-6. PubMed ID: 24788223
    [Abstract] [Full Text] [Related]

  • 13. [Measurement of calprotectin in faeces].
    Jahnsen J, Røseth AG, Aadland E.
    Tidsskr Nor Laegeforen; 2009 Apr 16; 129(8):743-5. PubMed ID: 19373299
    [Abstract] [Full Text] [Related]

  • 14. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA, Kolkman JJ, Russel MG, Vlaskamp RT, Vermes I.
    Ned Tijdschr Geneeskd; 2003 Nov 29; 147(48):2360-5. PubMed ID: 14677476
    [Abstract] [Full Text] [Related]

  • 15. Faecal calprotectin in the assessment of Crohn's disease activity.
    Gaya DR, Lyon TD, Duncan A, Neilly JB, Han S, Howell J, Liddell C, Stanley AJ, Morris AJ, Mackenzie JF.
    QJM; 2005 Jun 29; 98(6):435-41. PubMed ID: 15879440
    [Abstract] [Full Text] [Related]

  • 16. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
    Kallel L, Ayadi I, Matri S, Fekih M, Mahmoud NB, Feki M, Karoui S, Zouari B, Boubaker J, Kaabachi N, Filali A.
    Eur J Gastroenterol Hepatol; 2010 Mar 29; 22(3):340-5. PubMed ID: 19581809
    [Abstract] [Full Text] [Related]

  • 17. Faecal calprotectin concentrations in gastrointestinal diseases.
    Wang S, Wang Z, Shi H, Heng L, Juan W, Yuan B, Wu X, Wang F.
    J Int Med Res; 2013 Aug 29; 41(4):1357-61. PubMed ID: 23723365
    [Abstract] [Full Text] [Related]

  • 18. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM, Nisihara RM, Marion SB, Cavassani MF, Kotze PG.
    Arq Gastroenterol; 2015 Aug 29; 52(1):50-4. PubMed ID: 26017083
    [Abstract] [Full Text] [Related]

  • 19. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
    Oyaert M, Trouvé C, Baert F, De Smet D, Langlois M, Vanpoucke H.
    Clin Chem Lab Med; 2014 Mar 29; 52(3):391-7. PubMed ID: 24114912
    [Abstract] [Full Text] [Related]

  • 20. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
    Sydora MJ, Sydora BC, Fedorak RN.
    J Crohns Colitis; 2012 Mar 29; 6(2):207-14. PubMed ID: 22325175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.